616 related articles for article (PubMed ID: 25251730)
1. The role of Epstein-Barr virus in epithelial malignancies.
Tsao SW; Tsang CM; To KF; Lo KW
J Pathol; 2015 Jan; 235(2):323-33. PubMed ID: 25251730
[TBL] [Abstract][Full Text] [Related]
2. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
[TBL] [Abstract][Full Text] [Related]
3. The Epstein-Barr virus and the pathogenesis of lymphoma.
Vockerodt M; Yap LF; Shannon-Lowe C; Curley H; Wei W; Vrzalikova K; Murray PG
J Pathol; 2015 Jan; 235(2):312-22. PubMed ID: 25294567
[TBL] [Abstract][Full Text] [Related]
4. The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.
Tsang CM; Tsao SW
Virol Sin; 2015 Apr; 30(2):107-21. PubMed ID: 25910483
[TBL] [Abstract][Full Text] [Related]
5. Emerging roles of small Epstein-Barr virus derived non-coding RNAs in epithelial malignancy.
Lung RW; Tong JH; To KF
Int J Mol Sci; 2013 Aug; 14(9):17378-409. PubMed ID: 23979421
[TBL] [Abstract][Full Text] [Related]
6. EBV BART MicroRNAs Target Multiple Pro-apoptotic Cellular Genes to Promote Epithelial Cell Survival.
Kang D; Skalsky RL; Cullen BR
PLoS Pathog; 2015 Jun; 11(6):e1004979. PubMed ID: 26070070
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.
Zheng X; Wang J; Wei L; Peng Q; Gao Y; Fu Y; Lu Y; Qin Z; Zhang X; Lu J; Ou C; Li Z; Zhang X; Liu P; Xiong W; Li G; Yan Q; Ma J
J Virol; 2018 Dec; 92(23):. PubMed ID: 30209170
[TBL] [Abstract][Full Text] [Related]
8. EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.
Zhang J; Jia L; Tsang CM; Tsao SW
Adv Exp Med Biol; 2017; 1018():75-90. PubMed ID: 29052133
[TBL] [Abstract][Full Text] [Related]
9. Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region.
Marquitz AR; Mathur A; Edwards RH; Raab-Traub N
J Virol; 2015 Nov; 89(22):11256-68. PubMed ID: 26311882
[TBL] [Abstract][Full Text] [Related]
10. EBV-encoded miRNAs can sensitize nasopharyngeal carcinoma to chemotherapeutic drugs by targeting BRCA1.
Lung RW; Tong JH; Ip LM; Lam KH; Chan AW; Chak WP; Chung LY; Yeung WW; Hau PM; Chau SL; Tsao SW; Lau KM; Lo KW; To KF
J Cell Mol Med; 2020 Nov; 24(22):13523-13535. PubMed ID: 33074587
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr Virus Infection Promotes Epithelial Cell Growth by Attenuating Differentiation-Dependent Exit from the Cell Cycle.
Eichelberg MR; Welch R; Guidry JT; Ali A; Ohashi M; Makielski KR; McChesney K; Van Sciver N; Lambert PF; Keleș S; Kenney SC; Scott RS; Johannsen E
mBio; 2019 Aug; 10(4):. PubMed ID: 31431547
[TBL] [Abstract][Full Text] [Related]
12. Viral Carcinogenesis Beyond Malignant Transformation: EBV in the Progression of Human Cancers.
Elgui de Oliveira D; Müller-Coan BG; Pagano JS
Trends Microbiol; 2016 Aug; 24(8):649-664. PubMed ID: 27068530
[TBL] [Abstract][Full Text] [Related]
13. Clustered microRNAs of the Epstein-Barr virus cooperatively downregulate an epithelial cell-specific metastasis suppressor.
Kanda T; Miyata M; Kano M; Kondo S; Yoshizaki T; Iizasa H
J Virol; 2015 Mar; 89(5):2684-97. PubMed ID: 25520514
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus infection and its gene expression in gastric lymphoma of mucosa-associated lymphoid tissue.
Xu WS; Chan AC; Lee JM; Liang RH; Ho FC; Srivastava G
J Med Virol; 1998 Dec; 56(4):342-50. PubMed ID: 9829640
[TBL] [Abstract][Full Text] [Related]
15. The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers.
Tsai MH; Lin X; Shumilov A; Bernhardt K; Feederle R; Poirey R; Kopp-Schneider A; Pereira B; Almeida R; Delecluse HJ
Oncotarget; 2017 Feb; 8(6):10238-10254. PubMed ID: 28052012
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus infection in immortalized nasopharyngeal epithelial cells: regulation of infection and phenotypic characterization.
Tsang CM; Zhang G; Seto E; Takada K; Deng W; Yip YL; Man C; Hau PM; Chen H; Cao Y; Lo KW; Middeldorp JM; Cheung AL; Tsao SW
Int J Cancer; 2010 Oct; 127(7):1570-83. PubMed ID: 20091869
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control
Murer A; Rühl J; Zbinden A; Capaul R; Hammerschmidt W; Chijioke O; Münz C
mBio; 2019 Jan; 10(1):. PubMed ID: 30647153
[TBL] [Abstract][Full Text] [Related]
18. The oncogenic role of Epstein-Barr virus-encoded microRNAs in Epstein-Barr virus-associated gastric carcinoma.
Zhang J; Huang T; Zhou Y; Cheng ASL; Yu J; To KF; Kang W
J Cell Mol Med; 2018 Jan; 22(1):38-45. PubMed ID: 28990284
[TBL] [Abstract][Full Text] [Related]
19. Role of Viral and Host microRNAs in Immune Regulation of Epstein-Barr Virus-Associated Diseases.
Iizasa H; Kim H; Kartika AV; Kanehiro Y; Yoshiyama H
Front Immunol; 2020; 11():367. PubMed ID: 32194570
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr Virus miR-BART6-3p Inhibits the RIG-I Pathway.
Lu Y; Qin Z; Wang J; Zheng X; Lu J; Zhang X; Wei L; Peng Q; Zheng Y; Ou C; Ye Q; Xiong W; Li G; Fu Y; Yan Q; Ma J
J Innate Immun; 2017; 9(6):574-586. PubMed ID: 28877527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]